NSE · VENUSREM
Venus Remedies Limited
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#1,132
of 5,004 stocks
🏆 New peak
▲ 631W
Peak #1,132 · 01 Oct 2026
Venus Remedies Limited, a smallcap Healthcare business, is growing revenue at a solid clip, trades at a moderate earnings multiple, and earns a healthy return on equity.
Market Cap
2,401.39 Cr
P/E Ratio
23.36
P/B Ratio
3.62
ROE
15.48%
ROCE
19.39%
Dividend Yield
0.56%
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 178.86 Cr | 259.40 Cr | 180.26 Cr | 192.75 Cr |
| Net Profit | 22.97 Cr | 47.49 Cr | 25.58 Cr | 20.13 Cr |
| EPS | 17.18 | 35.53 | 19.14 | 15.06 |
| Operating Profit | 30.04 Cr | 61.61 Cr | 33.48 Cr | 26.50 Cr |
Shareholding pattern
Promoter
41.76%
Public
58.24%
Mutual fund holdings
₹0.00
Cr total
1
Schemes
1
Fund Houses
₹0.00 Cr
Total Exposure
Motilal Oswal Mutual Fund₹0.00 Cr (100.0%)
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 07 Aug 2026 | Dividend | Dividend - Rs 10 Per Share |
| 13 Sep 2024 | Other | Annual General Meeting |
| 17 Aug 2023 | Other | Annual General Meeting |
| 11 Aug 2022 | Other | Annual General Meeting |
| 09 Sep 2021 | Other | Annual General Meeting |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.